Nivolumab for Patients With Advanced Renal Cell Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
ESMO Open
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Nivolumab in patients with advanced renal cell carcinoma in France: interim results of the observational, real-world WITNESS study
ESMO Open 2024 Jun 18;9(7)103602, P Barthélémy, L Albigès, B Escudier, B Narciso, P Bigot, M Chehimi, S Emambux, F Calcagno, G Mouillet, JC Eymard, F Schlürmann, S Bailly, D Garbay, JF Berdah, MB Palmaro, MG Goupil, D Spaeth, S Néré, C Quentric, YA Vano, A Thiery-VuilleminFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Renal Cell Carcinoma Center of Excellence
Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.